162 related articles for article (PubMed ID: 21092168)
21. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.
Sevy S; Robinson DG; Holloway S; Alvir JM; Woerner MG; Bilder R; Goldman R; Lieberman J; Kane J
Acta Psychiatr Scand; 2001 Nov; 104(5):367-74. PubMed ID: 11722318
[TBL] [Abstract][Full Text] [Related]
22. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
[TBL] [Abstract][Full Text] [Related]
23. Schizophrenia and substance abuse.
Smith J; Hucker S
Br J Psychiatry; 1994 Jul; 165(1):13-21. PubMed ID: 7953023
[TBL] [Abstract][Full Text] [Related]
24. Reasons for increased substance use in psychosis.
Gregg L; Barrowclough C; Haddock G
Clin Psychol Rev; 2007 May; 27(4):494-510. PubMed ID: 17240501
[TBL] [Abstract][Full Text] [Related]
25. Psychoses and illicit drug use: need for cross-cultural studies.
Thirthalli J; Venkatesh BK; Gangadhar BN
Acta Psychiatr Scand; 2008 Jul; 118(1):86; author reply 86-7. PubMed ID: 18489616
[No Abstract] [Full Text] [Related]
26. Expectations and motives for substance use in schizophrenia.
Mueser KT; Nishith P; Tracy JI; DeGirolamo J; Molinaro M
Schizophr Bull; 1995; 21(3):367-78. PubMed ID: 7481568
[TBL] [Abstract][Full Text] [Related]
27. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
[TBL] [Abstract][Full Text] [Related]
28. A comparative study on schizophrenic patients with dual diagnosis.
Modestin J; Gladen CJ; Christen S
J Addict Dis; 2001; 20(4):41-51. PubMed ID: 11760925
[TBL] [Abstract][Full Text] [Related]
29. Courses of substance use and schizophrenia in the dual-diagnosis patients: is there a relationship?
Goswami S; Singh G; Mattoo SK; Basu D
Indian J Med Sci; 2003 Aug; 57(8):338-46. PubMed ID: 12944690
[TBL] [Abstract][Full Text] [Related]
30. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
[TBL] [Abstract][Full Text] [Related]
31. Using measures of readiness to change in individuals with schizophrenia.
Addington J; el-Guebaly N; Duchak V; Hodgins D
Am J Drug Alcohol Abuse; 1999 Feb; 25(1):151-61. PubMed ID: 10078983
[TBL] [Abstract][Full Text] [Related]
32. Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
Dixon L; Haas G; Weiden PJ; Sweeney J; Frances AJ
Am J Psychiatry; 1991 Feb; 148(2):224-30. PubMed ID: 1987823
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of psychotic symptoms in substance users: a comparison across substances.
Smith MJ; Thirthalli J; Abdallah AB; Murray RM; Cottler LB
Compr Psychiatry; 2009; 50(3):245-50. PubMed ID: 19374969
[TBL] [Abstract][Full Text] [Related]
34. Substance use among the mentally ill: prevalence, reasons for use, and effects on illness.
Warner R; Taylor D; Wright J; Sloat A; Springett G; Arnold S; Weinberg H
Am J Orthopsychiatry; 1994 Jan; 64(1):30-9. PubMed ID: 8147425
[TBL] [Abstract][Full Text] [Related]
35. Schizophrenia and hallucinogen persisting perception disorder: A clinical investigation.
Lev-Ran S; Feingold D; Rudinski D; Katz S; Arturo LG
Am J Addict; 2015 Apr; 24(3):197-199. PubMed ID: 25808913
[TBL] [Abstract][Full Text] [Related]
36. Thought, feeling, and action in real time--monitoring of drug use in schizophrenia.
Csernansky JG; Smith MJ
Am J Psychiatry; 2011 Feb; 168(2):120-2. PubMed ID: 21297046
[No Abstract] [Full Text] [Related]
37. Cannabis use and outcome of recent onset psychosis.
Grech A; Van Os J; Jones PB; Lewis SW; Murray RM
Eur Psychiatry; 2005 Jun; 20(4):349-53. PubMed ID: 16018929
[TBL] [Abstract][Full Text] [Related]
38. Frequency and predictive values of first rank symptoms at baseline among 362 young adult patients with first-episode schizophrenia Results from the Danish OPUS study.
Thorup A; Petersen L; Jeppesen P; Nordentoft M
Schizophr Res; 2007 Dec; 97(1-3):60-7. PubMed ID: 17698323
[TBL] [Abstract][Full Text] [Related]
39. [Aggressive behaviour and substance abuse among schizophrenic adolescents compared to antisocial adolescents--a follow-up study].
Sevecke K; Dreher J; Walger P; Junglas J; Lehmkuhl G
Z Kinder Jugendpsychiatr Psychother; 2005 Apr; 33(2):105-12. PubMed ID: 15900804
[TBL] [Abstract][Full Text] [Related]
40. [Dual diagnosis psychosis and substance use disorders: theoretical foundations and treatment].
Gouzoulis-Mayfrank E
Z Kinder Jugendpsychiatr Psychother; 2008 Jul; 36(4):245-53. PubMed ID: 18654956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
